- Life Expectancy Could Decline Worldwide Due to COVID-19
- Potential COVID-19 Drug Could Increase Heart Risk: Study
- Holidays Can Be a Fright for Kids With Food Allergies
- Clear Danger: Glass-Topped Tables Injure Thousands Each Year
- COVID Survivor Rita Wilson Wants You to Get Your Flu Shot
- U.S. COVID Death Toll Nears 200,000, While Cases Start to Climb Again
- Health Highlights: Sept. 21, 2020
- How to Help Ensure Your Students Get Enough Sleep
- A Guide to Acne Care for People of Color
- Supreme Court Justice Ruth Bader Ginsburg Dies at 87
Clinical Trials Update: Aug. 10, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Multiple Sclerosis
This study is evaluating an investigational product designed to enhance the central nervous system of adults with diagnosed relapsing, remitting or secondary progressive MS. To qualify, you must be aged 18 to 60 and attend eight overnight stays over a 22-week period.
The research site is in Phoenix, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/multiple_sclerosis.aspx.
—–
Hepatitis C
This study of an investigational drug is for people who have been treated unsatisfactorily for hepatitis C.
The research site is in La Mesa, Calif.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hepatitis.aspx.
—–
Systemic Lupus Erythematosus (SLE)
This study is for people diagnosed with systemic lupus erythematosus, specifically with high anti-dsDNA and anti-RNP.
The research site is in Everett, Wash.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/lupus.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
